Iodixanol
- Createtime： 2026-04-14
- Updatetime： 2026-09-30
Product Details
| useage |
Industrial use
|
| deliveryInfo |
|
| appearance |
powder
|
| Molecular Weight |
1550.18
|
| aliasen |
|
| supplyCapacity |
50000MT/Month
|
| harbor |
Qingdao,China
|
| minorder |
1KG
|
| Appearance |
White/off-white crystalline powder
|
Shandong Huashang Chemical Co., Ltd. is a high-tech enterprise specializing in the research and development, manufacturing, and sales of fine chemicals. Headquartered in Jinan, Shandong, China, we are committed to delivering high-quality products to our global partners. Currently, over 90% of our products are exported to developed markets, including North America, Europe, Japan, South Korea, and the Middle East.
Basic Information
Product Name: Iodixanol
CAS No: 92339-11-2
Molecular Formula: C??H??I?N?O??
Molecular Weight: 1550.18 g/mol
Classification: Nonionic dimeric hexaiodinated water-soluble X-ray contrast agent, pharmaceutical raw material
Physical & Chemical Properties
Appearance: White or off-white crystalline powder
Solubility: Highly soluble in water, soluble in methanol
Purity: ≥99.0% (HPLC)
Toxicity: Low acute toxicity; LD?? (mice, i.v.): 21 mg/kg
Main Uses
- Medical Imaging: Used for cardiovascular, cerebral, peripheral, and abdominal angiography; urography; venography; and CT enhancement scans.
- Pharmaceutical API: The active ingredient in injectable contrast media formulations.
Packaging & Storage
Packaging: 1kg, 5kg, 25kg sealed drums
Storage: Sealed, cool, dry, light-proof, and ventilated
Shelf Life: 24 months
Specification Table
| Item | Specification | Unit | Remarks |
| Product Name | Iodixanol | — | |
| CAS Number | 92339-11-2 | — | |
| Molecular Formula | C??H??I?N?O?? | — | |
| Molecular Weight | 1550.18 | g/mol | |
| Appearance | White/off-white crystalline powder | — | |
| Purity | ≥99.0 | % | HPLC |
| Solubility | Highly soluble in water, soluble in methanol | — | |
| Application | Nonionic X-ray contrast agent (API) | — | |
| Storage | Cool, dry, sealed, away from light | — | |
